ANALISIS BIAYA PASIEN SKIZOFRENIA MENGGUNAKAN TERAPI ANTIPSIKOTIK DI RSUD MADANI SULAWESI TENGAH : ANALISIS BIAYA PASIEN SKIZOFRENIA MENGGUNAKAN TERAPI ANTIPSIKOTIK DI RSUD MADANI SULAWESI TENGAH

Arya Dibyo Adisaputra; Muhammad Rinaldhi Tandah; Ruth Aruanlebok; Khusnul Diana

doi:10.29313/jiff.v7i1.2867

Authors

Arya Dibyo Adisaputra Universitas Tadulako
Muhammad Rinaldhi Tandah Universitas Tadulako
Ruth Aruanlebok Universitas Tadulako
Khusnul Diana Universitas Tadulako

DOI:

https://doi.org/10.29313/jiff.v7i1.2867

Keywords:

Cost analysis, Schizophrenic patients, Antipsychotics

Abstract

Treatment of schizophrenia cannot be separated from the burden of costs that must be borne by the patient. This study aims to determine the average direct medical costs with length of stay 14 days and >14 days from schizophrenia not classified (YTT), schizophrenia not detail and paranoid schizophrenia, knowing the average cost of antipsychotic monotherapy, combination 2, combination 3, combination 4 and combination 5 drugs from schizophrenia patients and knowing the average cost of direct medical components for schizophrenia patients at Madani Hospital, Central Sulawesi in 2019. This study is a type of non-experimental research that is analyzed descriptively and data collection is carrised out retrospectively from medical record data of schizophrenia patients in 2019. The results obtained from the cost analysis are the direct medical average costs of various types of schizophrenia, namely schizophrenia that is not classified (YTT) length of stay 14 days on average Rp 3,192,799±1,750,585 and length of stay >14 days Rp 6,107,006±2,465,655; unspecified schizophrenia length of stay 14 days an average of Rp 2,743,787±792,356 and length of stay >14 days an average of Rp 6,207,815±1,994,428 and paranoid schizophrenia length of stay 14 days an average of Rp 3,145,466± 3,145,466 and length of stay >14 days on average Rp 9,547,824±0; the average cost of antipsychotic treatment for schizophrenic patients, namely monotherapy treatment an average of IDR 36,266±8,457, a combination of 2 drugs an average of IDR 74,428, a combination of 3 drugs an average of IDR 44,279±32,746, a combination of 4 drugs an average of IDR 169,755±133,268, and a combination of 5 drugs an average of IDR 297,030 ± 0 and the average direct medical component cost that is most often incurred by schizophrenic patients is the cost of medical procedures with an average of IDR 1,468,907, or 33%.

References

Agung, W., & Fibriana, A. I. (2016). Faktor Resiko Terjadinya Skizofrenia (Studi Kasus di Wilayah Kerja Puskesmas Pati II). Public Health Perspective Journal, 1(1), 1–12. Retrieved from https://journal.unnes.ac.id/nju/index.php/phpj/article/view/7750.

Ariyani, F., Heriani, D., Muharni, N., & Husnawati. (2017). Analisis Efektivitas Biaya dan Terapi Antipsikotik Haloperidol-Klorpromazin dan Risperidon-Kolanzapin pada Pasien Skizofrenia. 14(01), 98–107. Retrieved from https://media.neliti.com/media/publications/269052-analisis-efektivitas-biaya-dan-terapi-an-5c784942.pdf.

Aryani, F., & Sari, O. (2016). Gambaran Pola Penggunaan Antipsikotik pada Pasien Skizofrenia di Ruang Rawat Inap Rumah Sakit Jiwa. Jurnal Manajemen Dan Pelayanan Farmasi, Volume 6 N, 35–40. Retrieved from https://journal.ugm.ac.id/jmpf/article/view/29401.

Astiti, R. S. (2017). Cost Analysis Penggunaan Antipsikotik pada Pasien Skizofrenia Poli Psikiatri di RSUD RA Kartini Jepara Tahun 2016. Retrieved from http://eprints.ums.ac.id/58739/20/NASKAH PUBLIKASI-203.pdf.

Azani, E. (2018). Analisis Biaya dan Autcome Terapi Penggunaan Antipsikotika Pada Pasien Rawat Inap Skizofrenia RSJD Surakarta Tahun 2017 (Universitas Setia Budi Surakarta). https://doi.org/10.1017/CBO9781107415324.004.

Dinas kesehatan. (2015). Profil Kesehatan Provinsi Sulawesi Tenga 2015. 1–291. Retrieved from https://dinkes.sultengprov.go.id/wp-content/uploads/2018/06/2015.pdf.

Dinas Kesehatan. (2017). Profil Kesehatan Provinsi Sulawesi Tengah Tahun 2017. https://doi.org/10.1007/978-3-8349-9424-0.

Ernest, E., Vuksic, O., Shepard-Smith, A., & Webb, E. (2017). Schizophrenia An Information Guide. Retrieved from https://www.camh.ca/-/media/files/guides-and-publications/schizophrenia-guide-en.pdf.

Fahrul, Mukaddas, A., & Faustine, I. (2014). Rasionalitas Penggunaan Antipsikotik pada Pasien Skizofrenia di Instalasi Rawat Inap Jiwa RSD Madani Provinsi Sulawesi Tengah Periode Januari-April 2014. Online Jurnal of Natural Science, 3(1), 40–46. Retrieved from file:///C:/Users/USER/Downloads/2981-9122-1-PB.pdf.

Handayani, W., Mukaddas, A., Tandah, M.R. (2015). Cost Effectiveness Analysis of Patients with Schizophrenia in Madani Hospital. Retrieved from https://www.taylorfrancis.com/chapters/edit/10.1201/9781315112756-57/cost-effectiveness-analysis-patients-schizophrenia-madani-hospital-tandah-mukaddas-handayani

Isnawati, I. A., Addiarto, W., & Yunita, R. (2020). Psikoterapi Self Help Group Pada Keluarga Pasien Skizofrenia. Sulawesi Selatan: Yayasan Ahmar Cendekia Indonesia. halaman 15.

Kementrian Kesehatan Republik Indonesia. (2018). Laporan Nasional Riset Kesehatan Dasar 2018. 1–582.

Kurniawan, H., Mirza, & Raihan. (2015). Hubungan Lamanya Perawatan Pasien Skizofrenia Dengan Stres Keluarga. 15(3), 179–189. https://doi.org/10.24815/jks.v15i3.3669

Manggalawati, P. (2016). Potensi Interaksi Obat Antipsikotik pada Pasien Skizofrenia Dewasa di Instalasi Rawat Inap Rumah Sakit Jiwa Daerah “X” periode Oktober – Desember Tahun 2015. Skripsi. Retrieved from http://eprints.ums.ac.id/44041/15/NASKAH PUBLIKASI .pdf

Melatiani. (2013). Analisis Biaya pada Pasien Skizofrenia Rawat Inap di Rumah Sakit “x” Surakarta tahun 2012. Skripsi, 0–15. Retrieved from http://eprints.ums.ac.id/27817/16/naskah_publikasi.pdf.

Novitayani, S. (2016). Karakteristik Pasien Skizofrenia dengan Riwayat Rehospitalisasi. Idea Nursing Journal, VII(2), 23–29. Retrieved from file:///C:/Users/USER/Downloads/6442-13546-1-SM.pdf.

Nugroho, wahyu W. (2017). Karakteristik Bahasa Toni Blank: Kajian Psikolinguistik, Teori, dan Praktik. Yogyakarta: Gadjah Mada University Press.

O’Brien, P. G., Kennedy, W. Z., & Ballaid, K. A. (2014). Keperawatan Kesehatan Jiwa Pskiatri: Teori dan Praktek. Jakarta: Penerbit buku kedokteran.

Rahaya, A., & Cahaya, N. (2016). Studi Retrospektif Penggunaan Trihexyfenidil Pada Pasien Skizofrenia Rawat Inap Yang Mendapat Terapi Antipskotik Di Rumah Sakit Jiwa Sambang Lihum. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 2(2), 124–131. https://doi.org/10.22487/j24428744.2016.v2.i2.5986.

Ranti, I., Octaviany, A. F., & Kinanti, S. (2015). Analisis Efektivitas Terapi dan Biaya antara Haloperidol Kombinasi dengan Risperidon Kombinasi pada Terapi Skizofrenia Fase Akut. Mutiara Medika, 15(1), 57–64. Retrieved from file:///C:/Users/USER/Downloads/2495-7027-1-PB (2).pdf.

Ratnasari, I. D. (2018). Analisis Drug Related Problems Penggunaan Antipsikotik Pada Penderita Schizophrenia Dewasa Di Rumah Sakit Jiwa X Surabaya Ike Desy Ratnasari. Jurnal Ilmiah Mahasiswa Universitas Surabaya, 7(1), 721–735. Retrieved from http://www.journal.ubaya.ac.id/index.php/jimus/article/view/1192.

Rini, W. S., & Rochman Hadjam, M. N. (2016). Efektivitas Remediasi Kognitif terhadap Perbaikan Fungsi Kognitif pada Penderita Skizofrenia Rawat Inap di Rumah Sakit Jiwa A di Yogyakarta. Gadjah Mada Journal of Professional Psychology (GamaJPP), 2(2), 112. https://doi.org/10.22146/gamajpp.33363.

Safiah, S., Livana, SP., & Sujarwo. (2016). Gambaran Karakteristik Pasien Emergency Psychiatric dengan Pemenuhan Nutrisi Kurang dari Kebutuhan Tubuh. 8(1), 1–8. Retrieved from file:///C:/Users/USER/Downloads/28-Article Text-35-2-10-20200820 (1).pdf.

Yunitasari, F. D., & Zulfa, I. M. (2018). Hospitalisasi Pasien Skizofrenia di Rumah Sakit Jiwa Menur Surabaya. Journal of Pharmacy and Science, 3(2), 51–54. Retrieved from https://media.neliti.com/media/publications/346160-hospitalisasi-pasien-skizofrenia-di-ruma-9d926f83.pdf.

Zahnia, S., & Wulan Sumekar, D. (2016). Kajian Epidemiologis Skizofrenia. 5(5), 160–166. Retrieved from http://juke.kedokteran.unila.ac.id/index.php/majority/article/view/904/812.